ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 084,50
-0,70%
Dow Jones
39 872,99
0,00%
DAX
18 664,75
-0,33%
Brent Oil
81,925
-0,63%
Bitcoin
69 893,58
-0,34%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Jasper Therapeutics Inc (JSPR)

  7. Jasper Therapeutics Inc (JSPR) Actualités

JSPR

Jasper Therapeutics (JSPR)

Jasper Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:JSPR
DateHeureSourceTitreSymboleSociété
05/03/202422h52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:JSPRJasper Therapeutics Inc
05/03/202422h02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:JSPRJasper Therapeutics Inc
04/03/202413h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JSPRJasper Therapeutics Inc
21/02/202401h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JSPRJasper Therapeutics Inc
10/02/202402h36Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:JSPRJasper Therapeutics Inc
02/02/202415h50Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:JSPRJasper Therapeutics Inc
20/11/202323h11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:JSPRJasper Therapeutics Inc
09/11/202322h01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:JSPRJasper Therapeutics Inc
09/11/202315h18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:JSPRJasper Therapeutics Inc
21/06/202312h00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:JSPRJasper Therapeutics Inc
21/06/202312h00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JSPRJasper Therapeutics Inc
20/06/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JSPRJasper Therapeutics Inc
28/04/202322h02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:JSPRJasper Therapeutics Inc
21/04/202322h06Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:JSPRJasper Therapeutics Inc
21/04/202322h04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:JSPRJasper Therapeutics Inc
21/04/202322h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:JSPRJasper Therapeutics Inc
14/04/202322h26Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:JSPRJasper Therapeutics Inc
08/03/202322h47Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:JSPRJasper Therapeutics Inc
08/03/202322h12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:JSPRJasper Therapeutics Inc
27/02/202322h06Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:JSPRJasper Therapeutics Inc
14/02/202314h27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:JSPRJasper Therapeutics Inc
06/02/202322h44Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JSPRJasper Therapeutics Inc
31/01/202322h16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:JSPRJasper Therapeutics Inc
25/01/202322h42Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:JSPRJasper Therapeutics Inc
10/11/202222h12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:JSPRJasper Therapeutics Inc
19/10/202212h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:JSPRJasper Therapeutics Inc
07/10/202222h07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:JSPRJasper Therapeutics Inc
12/08/202222h07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:JSPRJasper Therapeutics Inc
13/07/202214h32TipRanksCredit Suisse Thinks Jasper Therapeutics’ Stock is Going to RecoverNASDAQ:JSPRJasper Therapeutics Inc
13/05/202214h39TipRanksJasper Therapeutics (JSPR) Gets a Buy Rating from Credit SuisseNASDAQ:JSPRJasper Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:JSPR

Dernières Valeurs Consultées

NYSE
JPM
JP Morgan Chase
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
NVDA
NVIDIA
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
EU
EN
Bouygues
EU
VIV
Vivendi
EU
ML
Michelin
USI
USTECH100
US Tech 100
EU
RI
Pernod Ricard
NYSE
MCD
McDonalds
EU
ACA
Credit Agricole
EU
PX4
SBF 120
EU
HO
Thales
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés